...
首页> 外文期刊>The journal of immunology >Broadening the Repertoire of Functional Herpes Simplex Virus Type 1–Specific CD8+ T Cells Reduces Viral Reactivation from Latency in Sensory Ganglia
【24h】

Broadening the Repertoire of Functional Herpes Simplex Virus Type 1–Specific CD8+ T Cells Reduces Viral Reactivation from Latency in Sensory Ganglia

机译:扩大功能性疱疹病毒类型1特异性CD8 + T细胞的曲目可降低来自感官神经节的潜伏期的病毒再活化

获取原文

摘要

A large proportion of the world population harbors HSV type 1 (HSV-1) in a latent state in their trigeminal ganglia (TG). TG-resident CD8+ T cells appear important for preventing HSV-1 reactivation from latency and recurrent herpetic disease. In C57BL/6J mice, half of these cells are specific for an immunodominant epitope on HSV-1 glycoprotein B, whereas the other half are specific for 18 subdominant epitopes. In this study, we show that the CD8+ T cell dominance hierarchy in the TG established during acute infection is maintained during latency. However, CD8+ T cells specific for subdominant epitopes lose functionality, whereas those specific for the immunodominant epitope exhibit increased functionality in latently infected TG. Furthermore, we show that IL-10 produced by 16.4 ± 2.8% of TG-resident CD4+ T cells maintains the immunodominance hierarchy in part through selective inhibition of subdominant CD8+ T cell proliferation. Upon systemic anti–IL-10R Ab treatment, we observed a significant expansion of functional subdominant CD8+ T cells, resulting in significantly improved protection from viral reactivation. In fact, systemic anti–IL-10R Ab treatment prevented viral reactivation in up to 50% of treated mice. Our results not only demonstrate that HSV-1 reactivation from latency can be prevented by expanding the repertoire of functional TG-resident CD8+ T cells, but also that IL-10R blockade might have therapeutic potential to reduce or eliminate recurrent herpetic disease.
机译:在其三叉甘氨酸(TG)中,大部分世界人口HARBORS HSV型(HSV-1)在潜在的状态下进行潜在。 TG植物CD8 + T细胞对于预防潜水和复发性引入患者疾病的HSV-1重新激活似乎很重要。在C57BL / 6J小鼠中,这些细胞中的一半特异于HSV-1糖蛋白B上的免疫肿瘤表位,而另一半是针对18个亚底剂表位的特异性。在本研究中,我们表明在潜水期间维持在急性感染期间建立的TG中的CD8 + T细胞优势等级。然而,针对次躯体表位的CD8 + T细胞丧失功能,而免疫肿瘤表位的具体特定表现出潜在感染的TG的功能增加。此外,我们表明,通过选择性抑制亚滴下的CD8 + T细胞增殖,将IL-10产生16.4±2.8%的TG常规CD4 + T细胞。在全身抗IL-10R AB治疗后,我们观察到功能性亚下芽CD8 + T细胞的显着扩增,导致病毒再活化的显着改善。实际上,全身抗IL-10R AB治疗可防止高达50%处理的小鼠的病毒再活化。我们的结果不仅证明可以通过扩大功能性TG常规CD8 + T细胞的曲目来防止来自潜伏期的HSV-1重新激活,而且还可以防止IL-10R阻断可能具有减少或消除复发性引入患者的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号